ArticleOncogene2018

Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth.

Xia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.